Related references
Note: Only part of the references are listed.Automatic segmentation of gadolinium-enhancing lesions in multiple sclerosis using deep learning from clinical MRI
Sibaji Gaj et al.
PLOS ONE (2021)
Multiple Sclerosis Performance Test: validation of self-administered neuroperformance modules
S. M. Rao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent A Systematic Review and Meta-analysis
Sean A. Woolen et al.
JAMA INTERNAL MEDICINE (2020)
The prevalence of MS in the United States A population-based estimate using health claims data
Mitchell T. Wallin et al.
NEUROLOGY (2019)
Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis
Philipp Eisele et al.
MAGNETIC RESONANCE IMAGING (2019)
Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
Robert Zivadinov et al.
NEUROLOGY (2019)
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis
Sirio Cocozza et al.
NEURORADIOLOGY (2019)
Effect of different doses of gadolinium contrast agent on clinical outcomes in MS
Nathalie Ackermans et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2019)
Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients
Alessandra Splendiani et al.
RADIOLOGIA MEDICA (2018)
Gadolinium deposition in the brain: summary of evidence and recommendations
Vikas Gulani et al.
LANCET NEUROLOGY (2017)
Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting
Stephen M. Rao et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates
Robert J. McDonald et al.
RADIOLOGY (2017)
Gadolinium Deposition in Human Brain Tissues after Contrast-enhanced MR Imaging in Adult Patients without Intracranial Abnormalities
Robert J. McDonald et al.
RADIOLOGY (2017)
Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents
Yang Zhang et al.
RADIOLOGY (2017)
Processing speed test: Validation of a self-administered, iPad®-based tool for screening cognitive dysfunction in a clinic setting
Stephen M. Rao et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study
Y. Forslin et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
A. Traboulsee et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
J. Ramalho et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
Philippe Robert et al.
INVESTIGATIVE RADIOLOGY (2016)
Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience
Emanuel Kanal
MAGNETIC RESONANCE IMAGING (2016)
Quantifying brain volumes for Multiple Sclerosis patients follow-up in clinical practice - comparison of 1.5 and 3 Tesla magnetic resonance imaging
Andreas P. Lysandropoulos et al.
BRAIN AND BEHAVIOR (2016)
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations
Kunio Nakamura et al.
NEUROIMAGE (2015)
Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy
Tomonori Kanda et al.
RADIOLOGY (2015)
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging
Robert J. McDonald et al.
RADIOLOGY (2015)
Temporally Consistent Probabilistic Detection of New Multiple Sclerosis Lesions in Brain MRI
Colm Elliott et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2013)
Evaluating and reducing the impact of white matter lesions on brain volume measurements
Marco Battaglini et al.
HUMAN BRAIN MAPPING (2012)
BEaST: Brain extraction based on nonlocal segmentation technique
Simon F. Eskildsen et al.
NEUROIMAGE (2012)
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis
Gavin Giovannoni et al.
LANCET NEUROLOGY (2011)
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study
R. A. Bermel et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Unbiased nonlinear average age-appropriate brain templates from birth to adulthood
VS Fonov et al.
NEUROIMAGE (2009)
Multiple Sclerosis: Hyperintense Dentate Nucleus on Unenhanced T1-weighted MR Images Is Associated with the Secondary Progressive Subtype
Luca Roccatagliata et al.
RADIOLOGY (2009)
Relationship between MRI lesion activity and response to IFN-β in relapsing-remitting multiple sclerosis patients
J. Rio et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Symmetric diffeomorphic image registration with cross-correlation: Evaluating automated labeling of elderly and neurodegenerative brain
B. B. Avants et al.
MEDICAL IMAGE ANALYSIS (2008)
Validity of performance scales for disability assessment in multiple sclerosis
R. A. Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Share Paper
